DSHN >=98% (HPLC)

=98% (HPLC) href="ProdSupplierGNCB38378797_EN.htm">DSHN >=98% (HPLC) Suppliers list
Company Name: Shanghai Yu Ben Biotechnology Co., Ltd.  
Tel: 021-61350663 15502154572
Email: 1639466865@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: DuoYuchemtech.Co.Ltd.  
Tel: 15221991309
Email: 315346700@qq.com
Company Name: Energy Chemical  
Tel: 021-58432009 400-005-6266
Email: marketing@energy-chemical.com
Company Name: Beijing Biocreative Technology Co., Ltd.  
Tel: 15522676233
Email: 3007606172@qq.com

DSHN >=98% (HPLC) manufacturers

  • DSHN
  • DSHN pictures
  • $1980.00
  • 2026-05-21
  • CAS:313952-63-5
  • Purity:
  • Supply Ability: 10g
DSHN >=98% (HPLC) Basic information
Product Name:DSHN >=98% (HPLC)
Synonyms:DSHN >=98% (HPLC);2-Naphthalenecarboxylic acid, 5-[(diethylamino)sulfonyl]-3-hydroxy-;5-(N,N-Diethylsulfamoyl)-3-hydroxy-2-naphthoic acid
CAS:313952-63-5
MF:C15H17NO5S
MW:323.36
EINECS:
Product Categories:
Mol File:313952-63-5.mol
DSHN >=98% (HPLC) Structure
DSHN >=98% (HPLC) Chemical Properties
Boiling point 519.7±60.0 °C(Predicted)
density 1.387±0.06 g/cm3(Predicted)
pka2.73±0.30(Predicted)
Safety Information
MSDS Information
DSHN >=98% (HPLC) Usage And Synthesis
DescriptionDSHN is a novel activator of small heterodimer partner (SHP, NR0B2). DSHN transcriptionally activates SHP mRNA, but also stabilizes the SHP protein by preventing its ubiquitination and degradation.
UsesDSHN is a potent small heterodimer partner (SHP) activator. DSHN inhibits Ccl2 expression and secretion by inhibiting p65 activation of Ccl2 promoter activity. DSHN can be used in research of cancer[1].
DefinitionChEBI: 5-(diethylsulfamoyl)-3-hydroxy-2-naphthalenecarboxylic acid is a member of naphthalenes and a sulfonic acid derivative.
in vivoDSHN transcriptionally activated Shp mRNA, but also stabilized the SHP protein by preventing its ubiquitination and degradation. Second, this study identified Ccl2 as a new SHP target gene by RNA-seq. This study showed that activation of SHP by DSHN repressed Ccl2 expression and secretion by inhibiting p65 activation of CCL2 promoter activity, as demonstrated in vivo in Shp-/- mice and in vitro in HCC cells with SHP overexpression and knockdown._x000D_ _x000D_ Reference: Mol Cancer Ther. 2016 Oct;15(10):2294-2301. https://pubmed.ncbi.nlm.nih.gov/27486225/
targetDSHN is a novel activator of small heterodimer partner (SHP, NR0B2).
References[1] Yang Z, et, al. A Novel Small Molecule Activator of Nuclear Receptor SHP Inhibits HCC Cell Migration via Suppressing Ccl2. Mol Cancer Ther. 2016 Oct;15(10):2294-2301. DOI:10.1158/1535-7163.MCT-16-0153
DSHN >=98% (HPLC) Preparation Products And Raw materials
Tag:DSHN >=98% (HPLC)(313952-63-5) Related Product Information
SHP836 1H-Isoindole-1,3(2H)-dione, 4-[[14-[4-[[[1-[6-amino-5-(2,3-dichlorophenyl)-2-pyrazinyl]-4-methyl-4-piperidinyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-3,6,9,12-tetraoxatetradec-1-yl]amino]-2-(2,6-dioxo-3-piperidinyl)- 4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- Methanone, [4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-2-chloro-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidin-6-yl](tetrahydro-4-methoxy-2H-pyran-4-yl)- 2-Pyrazinemethanol, 6-[(2-amino-3-chloro-4-pyridinyl)thio]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]dec-8-yl]-5-methyl- 5-Quinolinesulfonic acid, 8-hydroxy-7-(6-sulfo-2-naphthylazo)-